Protective layer on skin, mucous membrane or other body tissue

Claim 3

The method of claim 1 wherein said hydrophilic lipid crystals consist of thin leaves having on their surface a substantially monomolecular layer in which polar end groups face outwardly toward the surface of the crystal to provide a hydrophilic characteristic.

Claim 4

The method of claim 1 wherein said ointment comprises 1 part by weight of an aqueous suspension containing 10-40 percent by weight of hydrophilic lipid crystals and 0.5-4 parts by weight of an aqueous solution containing 3-8 percent by weight of said alginic acid salt.

Claim 5

The method of claim 1 wherein said calcium salt comprises calcium acetate.

Claim 6

The method of claim 1 wherein the calcium salt is applied in the form of an aqueous solution comprising 10-30 percent of calcium salt.

Claim 7

An ointment comprising 70-90 percent by weight of an aqueous phase, 8-25 percent by weight of hydrophilic lipid crystals dispersed in said aqueous phase, said lipid crystals being selected from the group consisting of an alpha monoglyceride of a saturated fatty acid having 12-18 carbon atoms in the carbon chain, a glycerol monoether of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and an alkali metal salt of a phosphate ester of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and 1-7 percent by weight of a water-soluble salt of alginic acid dissolved in said aqueous phase, said salt having an average molecular weight of from 15,000 to 90,000.

Claim 8

An ointment comprising 70-90 percent by weight of an aqueous phase, 8-25 percent by weight of hydrophilic lipid crystals dispersed in said aqueous phase, said lipid crystals being selected from the group consisting of an alpha monoglyceride of a saturated fatty acid having 12-18 carbon atoms in the carbon chain, a glycerol monoether of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and an alkali metal salt of a phosphate ester of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and 1-7 percent by weight of a water-soluble salt of alginic acid dissolved in said aqueous phase, said salt having an average molecular weight of from 15,000 to 90,000.

Claim 9

A two component composition for producing a protective layer on a surface selected from the group consisting of skin and mucous membrane, a first component in the form of an ointment comprising 70-90 percent by weight of an aqueous phase, 1-7 percent by weight of a soluble salt of alginic acid having an average molecular weight of 15,000 to 90,000 and 8-25 percent by weight of hydrophilic lipid crystals dispersed in said aqueous phase, said hydrophilic lipid crystals being selected from the group consisting of an alpha monoglyceride of a saturated fatty acid having 12-18 carbon atoms in the carbon chain, a glycerol monoether of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and an alkali metal salt of a phosphate ester of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, said ointment being intended for application on said surface, and a second component comprising an aqueous solution of a water-soluble calcium salt for use in converting said water soluble salt to an insoluble calcium salt of alginic acid, said second component being intended for application on top of said ointment after said ointment has been applied to said surface, the concentration of said water-soluble calcium salt being sufficient to convert at least said soluble alginic acid salt in the upper portion of the ointment on said surface to said insoluble calcium salt.

Claim 10

A two component composition for producing a protective layer on a surface selected from the group consisting of skin and mucous membrane, a first component in the form of an ointment comprising 70-90 percent by weight of an aqueous phase, 1-7 percent by weight of a soluble salt of alginic acid having an average molecular weight of 15,000 to 90,000 and 8-25 percent by weight of hydrophilic lipid crystals dispersed in said aqueous phase, said hydrophilic lipid crystals being selected from the group consisting of an alpha monoglyceride of a saturated fatty acid having 12-18 carbon atoms in the carbon chain, a glycerol monoether of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, and an alkali metal salt of a phosphate ester of a saturated fatty alcohol having 12-18 carbon atoms in the carbon chain, said ointment being intended for application on said surface, and a second component comprising an aqueous solution of a water-soluble calcium salt for use in converting said water soluble salt to an insoluble calcium salt of alginic acid, said second component being intended for application on top of said ointment after said ointment has been applied to said surface, the concentration of said water-soluble calcium salt being sufficient to convert at least said soluble alginic acid salt in the upper portion of the ointment on said surface to said insoluble calcium salt.